Cargando…
Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
BACKGROUND: Recently studies had showed that the amygdala may take part in the cognitive impairment in schizophrenia (SC). However, the mechanism is still unclear, so we explored the relationship between the amygdala resting state magnetic resonance imaging (rsMRI) signal and cognitive function, to...
Autores principales: | Guo, Huagui, Ye, Haibiao, Li, Zhijian, Li, Xuesong, Huang, Wei, Yang, Yu, Xie, Guojun, Xu, Caixia, Li, Xiaoling, Liang, Wenting, Jing, Huan, Zhang, Chunguo, Tang, Chaohua, Liang, Jiaquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074687/ https://www.ncbi.nlm.nih.gov/pubmed/37020192 http://dx.doi.org/10.1186/s12888-023-04728-6 |
Ejemplares similares
-
Abnormalities of the Amygdala in schizophrenia: a real world study
por: Zheng, Guangen, et al.
Publicado: (2023) -
Differences of resting fMRI and cognitive function between drug-naïve bipolar disorder and schizophrenia
por: Liang, Jiaquan, et al.
Publicado: (2022) -
Differences and correlations of biochemical index levels in patients with bipolar disorder and major depressive disorder during a stable period
por: Tan, Yukang, et al.
Publicado: (2023) -
Deviant spontaneous neural activity as a potential early-response predictor for therapeutic interventions in patients with schizophrenia
por: Jing, Huan, et al.
Publicado: (2023) -
Abnormal blood lipid and electrocardiogram characteristics in common mental disorders
por: Li, Yan, et al.
Publicado: (2023)